Open access
Open access
Powered by Google Translator Translator

Cardiology

No amount of alcohol is good for the heart, says World Heart Federation.

24 Jan, 2022 | 08:23h | UTC

News Release: No amount of alcohol is good for the heart, says World Heart Federation

Report: The Impact of Alcohol Consumption on Cardiovascular Health: Myths and Measures – World Heart Federation

Commentary: No amount of alcohol is good for the heart, new report says, but critics disagree on science – CNN

 


AHA Statement: Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease.

24 Jan, 2022 | 08:21h | UTC

News Release: Oral penicillin, not injectable, advised for people with high-risk rheumatic heart disease – American Heart Association

See Guidance: Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association – Journal of the American Heart Association

 


Review: Health literacy interventions for secondary prevention of coronary artery disease.

24 Jan, 2022 | 08:12h | UTC

Health literacy interventions for secondary prevention of coronary artery disease: a scoping review – openheart

 


Retrospective cohort study: Occurrence and predictors of pericardial effusion requiring invasive treatment following heart valve surgery.

24 Jan, 2022 | 08:10h | UTC

Occurrence and predictors of pericardial effusion requiring invasive treatment following heart valve surgery – openheart

 


Review: Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat.

24 Jan, 2022 | 08:09h | UTC

Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat – Heart

 


KDOQI US commentary on the 2021 KDIGO Guideline for the management of blood pressure in chronic kidney disease.

24 Jan, 2022 | 07:56h | UTC

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD – American Journal of Kidney Diseases

Related:

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Guideline synopsis: management of blood pressure in patients with chronic kidney disease not receiving dialysis.

 

Commentary on Twitter

 


Perioperative guidelines on antiplatelet and anticoagulant agents: 2022 Update.

21 Jan, 2022 | 09:53h | UTC

Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update – Current Anesthesiology Reports

 


M-A: In patients with acute coronary syndrome, a guided approach (i.e., platelet function or genetic testing) to P2Y12 inhibiting therapy may reduce major adverse cardiovascular events without increased risk of bleeding.

21 Jan, 2022 | 09:33h | UTC

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials – European Heart Journal (link to abstract – $ for full-text)

Commentary: Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis – TCTMD

 

Commentary on Twitter

 


M-A: In comatose survivors of cardiac arrest, targeted hypothermia is not associated with improved survival or better neurological outcomes vs. targeted normothermia.

21 Jan, 2022 | 09:29h | UTC

Targeted Hypothermia Versus Targeted Normothermia In Survivors of Cardiac Arrest: A Systematic Review and Meta-Analysis of Randomized Trials – American Journal of Medicine

Related:

RCT: In comatose survivors of out-of-hospital cardiac arrest, there was no difference in mortality and neurologic outcomes with mild (target temperature of 34 °C) vs. moderate therapeutic hypothermia (target temperature of 31 °C).

M-A: Targeted temperature management following out-of-hospital cardiac arrest – “Routine use of moderate or deep hypothermia in comatose survivors of OHCA may potentially be associated with more harm than benefit”.

RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.

 


Heart function recovered quickly in children with COVID-19-related multisystem inflammatory syndrome (MIS-C).

20 Jan, 2022 | 09:26h | UTC

News Release: Heart function recovered quickly in children with COVID-19-related MIS-C condition – American Heart Association

Original Study: Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID‐19 Infections – Journal of the American Heart Association

 


Systematic Review: Prevalence, incidence and survival of heart failure.

20 Jan, 2022 | 09:00h | UTC

Prevalence, incidence and survival of heart failure: a systematic review – Heart

 


M-A: Association of Sodium-Glucose Cotransporter 2 Inhibitors with cardiovascular outcomes in patients with Type 2 Diabetes and other risk factors for cardiovascular disease.

20 Jan, 2022 | 08:42h | UTC

Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis – JAMA Network Open

 

Commentary on Twitter

 


M-A: Beta-blockers and renin–angiotensin system inhibitors may provide a modest benefit for the preservation of left ventricular function in patients with breast cancer treated with anthracyclines or trastuzumab.

19 Jan, 2022 | 08:34h | UTC

A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer – European Journal of Cardiology (link to abstract – $ for full-text)

Commentary: BBs, ACEI/ARBs to Prevent LV Dysfunction Due to Breast Cancer Drugs – American College of Cardiology

 


Practical guide to cardiopulmonary exercise testing in adults.

19 Jan, 2022 | 08:26h | UTC

Practical guide to cardiopulmonary exercise testing in adults – Respiratory Research

 


Pro-Con Debate: Cardiac Troponin measurement as part of routine follow-up of myocardial damage following noncardiac surgery.

18 Jan, 2022 | 09:36h | UTC

Pro-Con Debate: Cardiac Troponin Measurement as Part of Routine Follow-up of Myocardial Damage Following Noncardiac Surgery – Anesthesia & Analgesia

 


Podcast: Lower Extremity Edema Pearls.

18 Jan, 2022 | 09:33h | UTC

#316 Lower Extremity Edema – The Curbsiders

 


A national cohort study in Sweden showed pregnancy complications (preeclampsia or eclampsia, gestational hypertension, gestational diabetes, preterm birth, small for gestational age, and stillbirth) are associated with increased risk of cardiovascular disease later in life.

18 Jan, 2022 | 09:26h | UTC

Pregnancy Complications and Risk of Cardiovascular Disease Later in Life: A Nationwide Cohort Study – Journal of the American Heart Association

 


Review: Myocardial infarction with non-obstructive coronary artery disease.

18 Jan, 2022 | 09:24h | UTC

Myocardial infarction with non-obstructive coronary artery disease – EuroIntervention

Related:

MINOCA from A to Z – American College of Cardiology

Guidelines for the Management of Myocardial Infarction/injury with Non-obstructive Coronary Arteries (MINOCA)

Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non‐Obstructive Coronary Arteries

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association

The What, When, Who, Why, How and Where of Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) – Circulation Journal

Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries – Circulation

Nonobstructive Versus Obstructive Coronary Artery Disease in Acute Coronary Syndrome: A Meta‐Analysis – Journal of the American Heart Association

 


RCT: Vitamin D supplementation is not beneficial for the prevention of cardiovascular disease and cancer.

16 Jan, 2022 | 23:11h | UTC

Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial-a randomized controlled trial – American Journal of Clinical Nutrition

News Release: Five years of high-dose vitamin D did not affect incidence of cardiovascular disease or cancer – University of Eastern Finland

Related:

Randomized Trial: Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

Meta-Analysis: Vitamin D Not Effective for Cardiovascular Disease Prevention

Association between vitamin D supplementation and mortality: systematic review and meta-analysis – The BMJ

USPSTF Draft Statement: Insufficient evidence to recommend multivitamin supplements for the prevention of CVD or cancer. The statement also recommends against the use of beta-carotene (increases risk of CVD mortality and lung cancer) or vitamin E (clear evidence of no benefit)

Vitamin D, calcium, other vitamins, and supplements do not prevent cardiovascular diseases

Research: Circulating vitamin D concentration and risk of seven cancers

Research: Vitamin D and risk of total and site specific cancers

 


Perspective: Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age.

16 Jan, 2022 | 22:53h | UTC

Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age – Family Medicine and Community Health

Commentaries:

Researchers urge: ‘Prescribe aspirin based on benefit-to-risk not age’ – Florida Atlantic University

Preventive Aspirin Should Be Based on Benefit, Not Age – HealthDay

Related: USPSTF draft statement revises previous guidance and now recommends against initiating low-dose aspirin use for the primary prevention of CVD in adults aged 60 years or older.

 


Review | Travelling with heart failure: risk assessment and practical recommendations.

16 Jan, 2022 | 22:46h | UTC

Travelling with heart failure: risk assessment and practical recommendations – Nature Reviews Cardiology (if this link is paywalled, try this one)

 


Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

14 Jan, 2022 | 08:39h | UTC

Perioperative Cardiovascular Considerations Prior to Elective Noncardiac Surgery in Patients With a History of COVID-19 – JAMA Surgery

Related:

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 


In a prospective transcatheter aortic valve implantation (TAVI) registry, five-year outcomes showed patients with mild paravalvular regurgitation had increased mortality risk.

14 Jan, 2022 | 08:21h | UTC

Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation – EuroIntervention (link to abstract – $ for full-text)

 


Feature | The top ten: key trials in 2021 making a difference in cardiology clinical practice.

14 Jan, 2022 | 08:22h | UTC

Feature | The Top Ten: Key Trials in 2021 Making a Difference in Clinical Practice – American College of Cardiology

 


Systematic Review: In patients with intermittent claudication, Propionyl‐L‐carnitine may improve walking distance when compared to placebo (moderate overall certainty of evidence).

14 Jan, 2022 | 08:02h | UTC

Propionyl‐L‐carnitine for intermittent claudication – Cochrane Library

Summary: Propionyl-L-carnitine for intermittent claudication – Cochrane Library

 


Stay Updated in Your Specialty

No spam, just news.